Larry Lasky, PhD

Larry Lasky, PhD

Position: Partner

Dr. Lasky joined The Column Group in 2014. He has worked in the biotechnology industry for over 30 years. In 1981, he was a founding scientist of Genetics Institute, acquired by Wyeth, one of the earliest biotechnology companies.

He was subsequently a leading scientist at Genentech and eventually a Genentech Fellow. He worked in various disciplines including vaccinology, immunology, stem cell biology, cellular signaling mechanisms, and monoclonal antibody therapy of tumors. He is a co-author on over 135 publications and a co-inventor on 37 issued and pending patents.

Board of Directors: eFFECTOR Therapeutics, Revolution Medicines, Accent Therapeutics

Scientific Advisory Board: Ribon Therapeutics, Accent Therapeutics, RAPT Therapeutics

Scroll to Top